Search our Database of Scientific Publications and Authors

I’m looking for a

    Details and Download Full Text PDF:
    Big heart, small ring.

    • Authors:
    • Igor Kravets
      Stony Brook University School of Medicine
    Cleve Clin J Med 2017 Dec;84(12):925-933
    Assistant Professor of Medicine, Division of Endocrinology, Stony Brook University School of Medicine, Stony Brook, NY, USA.
    PDF Download - Full Text Link
    ( Please be advised that this article is hosted on an external website not affiliated with
    Source Status ListingPossible

    Similar Publications

    Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure.
    J Am Coll Cardiol 1996 Mar;27(3):633-41
    Department of Cardiology, University of Vienna, Austria.
    Objectives: This study sought to test the hypothesis that big endothelin-1 plasma levels in advanced heart failure are related to survival.

    Background: In heart failure, production of the potent vasoconstrictor endothelin-1 is increased. Because elevation of immunoreactive endothelin-1 in severe heart failure is primarily related to the precursor "big" endothelin-1, increased big endothelin-1 levels may be associated with a poor prognosis. Read More
    Chromosome-like organization of an asymmetrical ring polymer confined in a cylindrical space.
    Soft Matter 2015 Nov;11(41):8179-93
    Department of Physics and Astronomy, University of Waterloo, Waterloo, Ontario, Canada N2L 3G1.
    To what extent does a confined polymer show chromosome-like organization? Using molecular dynamics simulations, we study a model Escherichia coli (E. coli) chromosome: an asymmetrical ring polymer, formed by small monomers on one side and big monomers on the other confined in a concentric-shell or simple cylinder with closed ends. The ring polymer is organized in the way observed for the E. Read More
    Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
    Chest 2000 Jun;117(6):1713-9
    Departments of Internal Medicine II, University of Vienna, Austria.
    Study Objective: To compare hemodynamics and plasma big endothelin levels in patients awaiting heart transplantation who are receiving continuous IV therapy, and to establish their respective potency for predicting future cardiac events.

    Design: A randomized, prospective trial of ambulatory continuous treatment with IV prostaglandin E(1) (PGE(1)) vs dobutamine. A subanalysis was conducted of all patients who completed 4 weeks of follow-up in regard to treatment effects on hemodynamics and big endothelin plasma levels. Read More
    The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT).
    J Card Fail 2006 Jun;12(5):375-80
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
    Background: Endothelin is elevated in heart failure and contributes to neurohormonal activation, hemodynamic deterioration, and cardiovascular remodeling. Here, we examined its prognostic value in a large population of patients with chronic heart failure.

    Methods And Results: Big endothelin-1 (Big ET-1) and 4 other neurohormones were measured at study entry in 2359 patients enrolled in the Valsartan Heart Failure Trial (Val-HeFT) and their concentrations related to outcome over a median follow-up of 23 months. Read More